Chemotherapy in metastatic prostate cancer experience exchange

Click here for Prescribing Information

Dr Alison Birtle, Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer, Lancashire Teaching Hospitals NHS Foundation Trust

How do you define and monitor for disease progression?



Back to questions